AJ
Insider
Andrea S. James
Chief Financial OfficerAndrea S. James (Chief Financial Officer) filed 1 Form 4 report in the past 24 months (1 purchase, 0 sales), most often in OCX. The largest single filing was $200K of OCX (97,561 sh × $2.05, as filed), executed Feb 7 2025. The median gap between execution and disclosure was 4 days.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
purchases not yet priced
Delay-adjustediThe same average, entered at disclosure dates
–
purchases not yet priced
Filings, ttm
1
1 buys · 0 sells
Median delay
4d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$200K
shares × price, as filed
Last traded
Feb 7 2025
Filed Feb 11 2025
100% of their measured filings could not be priced (delisted or unquoted names). The returns above cover only what still trades.
Open performance→Volume by month
Buys $200K
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Not on file
1 filing
Sector per market data · by filing · past 24 months
Most traded names
OCX
OCX
OCX · 1 buy · 0 sells
1 filing
Recent filings
OCXPURCHASE
Oncocyte Corp
View filing →
$200K97,561 sh × $2.05
Exec Feb 7 2025
Filed Feb 11 2025 · 5:30 PM ET